Clinical Trials

24 enrolled

Neoplasms, Endometrial Neoplasms

NCT00997009 2023-11-14

MITO CERV 2

108 enrolled

Uterine Cervical Neoplasms

NCT00657878 2023-11-13

MITO-8

215 enrolled

Ovarian Neoplasms

NCT03503786 2023-11-13

MITO END-3

125 enrolled

Endometrial Neoplasms

NCT02584478 2023-11-08

AL3818

294 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00411138 2023-10-11

PORTEC-3

670 enrolled

Endometrial Neoplasms

NCT04201561 2023-06-26

SELENIUM

68 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases

NCT00326456 2023-03-27

MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer

820 enrolled

Ovarian Neoplasms

NCT00660842 2023-03-24

MITO-7

800 enrolled

Ovarian Neoplasms, Neurotoxicity Syndromes

NCT01706120 2023-03-24

MITO16/MANGO-2

Phase 4 Unknown

400 enrolled

Ovarian Neoplasms

NCT01802749 2023-03-24

MITO16MANGO2b

406 enrolled

Ovarian Neoplasms

NCT03410784 2023-03-24

MITO28MaNGOov4

72 enrolled

Ovarian Neoplasms

NCT05772377 2023-03-16

Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer

36 enrolled

To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer

NCT03321188 2023-02-06

Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients

20 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02125513 2022-12-30

GOGER-01

129 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05446883 2022-11-30

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

498 enrolled

Uterine Cervical Neoplasms

NCT02562365 2022-07-27

ACTS

130 enrolled

Ovarian Neoplasms

NCT03794778 2022-07-18

Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

Phase 4 Unknown

396 enrolled

Carcinoma, Ovarian Epithelial

NCT02639650 2022-06-03

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

214 enrolled

Gestational Trophoblastic Disease

NCT04772001 2022-05-18

Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer

Phase NA Unknown

53 enrolled

Uterine Cervical Neoplasms

NCT05158062 2022-04-26

Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

35 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

63 enrolled 16 charts

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

NCT05151549 2021-12-09

A Study of Carilizumab Combined With Concurrent Chemoradiotherapy

46 enrolled

Uterine Cervical Neoplasms

NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

813 enrolled 14 charts

Endometrial Clear Cell Adenocarcinoma

NCT04974944 2021-10-01

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

172 enrolled

Uterine Cervical Neoplasms

NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

637 enrolled 18 charts

GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01366183 2021-09-30

Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Unknown

290 enrolled

Fallopian Tube Neoplasms

NCT02065687 2021-09-30

Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer

Phase 2/3 Unknown

469 enrolled 16 charts

Endometrial Adenocarcinoma

NCT04731038 2021-09-17

Combination Therapy for First Line Treatment of Advanced Cervical Cancer

Phase 1 Unknown

20 enrolled

Advanced Cervical Cancer

NCT03462212 2021-08-27

MITO25

290 enrolled

Fallopian Tube Neoplasms

NCT04238988 2021-08-27

MITO CERV 3

45 enrolled

Locally Advanced Cervical Cancer

NCT04974827 2021-08-10

A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer

46 enrolled

Uterine Cervical Neoplasms

NCT04072263 2021-04-01

OVACURE

12 enrolled

Ovarian Cancer Recurrent

NCT02822157 2021-01-29

CLIO

160 enrolled

Carcinoma, Ovarian Epithelial

NCT04661696 2020-12-10

Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer.

75 enrolled

Ovarian Neoplasms

NCT04590625 2020-10-19

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

58 enrolled

Ovarian Neoplasms

NCT03912415 2020-09-18

FERMATA

316 enrolled

Uterine Cervical Neoplasms

NCT00652119 2020-08-19

Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin

Phase 1 Unknown

46 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04261465 2020-02-07

NUVOLA

35 enrolled

High Grade Serous Ovarian Cancer

NCT03693248 2019-12-10

ROCOCO

298 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03912402 2019-05-09

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

49 enrolled

Uterine Cervical Neoplasms

NCT01295502 2019-03-12

Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer

Phase 1 Unknown

45 enrolled

Uterine Cervical Neoplasms

NCT01650376 2018-03-23

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

52 enrolled

Ovarian Neoplasms, Recurrence, Uterine Neoplasms

NCT02629718 2018-03-16

SYSGO-003

700 enrolled

Uterine Cervical Neoplasms

NCT03095001 2017-04-13

Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion

70 enrolled

Ovarian Neoplasms

NCT02036164 2017-04-06

ACT-LACC

500 enrolled

Uterine Cervical Neoplasms

NCT02437812 2017-02-28

Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian Carcinoma

30 enrolled

Carcinoma, Ovarian Epithelial

NCT02039791 2015-08-19

Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer

20 enrolled

Uterine Cervical Neoplasms

NCT02492503 2015-07-08

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

40 enrolled